Jeffers SA, et al, Journal (2004), cited as Ref 45 in DOI: 10.1016/j.clim.2020.108427 (Q11288)
Revision as of 17:16, 25 June 2020 by Admin (talk | contribs) (Created claim: Property:P93: CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus, #quickstatements; #temporary_batch_1593105300644)
Cited in: "COVID-19 pathophysiology: A review" Clin Immunol; 2020 Apr 20 108427.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Jeffers SA, et al, Journal (2004), cited as Ref 45 in DOI: 10.1016/j.clim.2020.108427
|
Cited in: "COVID-19 pathophysiology: A review" Clin Immunol; 2020 Apr 20 108427.
|
Statements
Journal
0 references
2004
0 references
Jeffers SA
0 references
Tusell SM
0 references
Gillim-Ross L
0 references
Hemmila EM
0 references
Achenbach JE
0 references
Babcock GJ
0 references
Thomas WD;suffix:Jr
0 references
Thackray LB
0 references
Young MD
0 references
Mason RJ
0 references
Ambrosino DM
0 references
Wentworth DE
0 references
Demartini JC
0 references
Holmes KV
0 references
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus (English)
0 references
